JEFFERSON, N.C., Aug. 5 /PRNewswire/ -- Next Safety, Inc. (NSI) announces advanced respirators that give people more confidence to go to work in a pandemic environment. Next Safety is releasing for sale to the public respirator products the company developed for the bird flu influenza A subtype H5N1.
The respirators were originally developed for the bird flu (H5N1), which never became contagious. The Next Safety respirators are now being sold to the public for the first time. These respirators are a cross functional platform that supply highly purified air to half facemasks and air supply hoods.
Next Safety designed its respirators with input from the CDC and the World Health Organization along from the US army's famed AMRIID bioterrorism warfare center.
Next Safety's core competence is the development, design and rapid production of pulmonary products like its 9000 series respirators. Next Safety respirators are rated for 30,000 hours of continuous operation.
Next Safety respirator products are fabricated from battlefield-grade medical plastics. Next Safety uses compound filters that do not fail. Texas Instruments and EBM-Pabst power Next Safety's respirator products.
As with all respirator products, to be effective, Next Safety respirators must be used with proper eye protection and with a well-defined and understood decontamination program.
Next Safety is a leader in the development of pulmonary health products. It has a product line of advanced respirators that were developed for many different applications.
The company also develops pulmonary drug delivery products. It is a leader in the development of nicotine delivery devices for smoking cessation and nicotine replacement products.
Next Safety has 28 US patents that are either issued are pending for its products.
|SOURCE Next Safety, Inc.|
Copyright©2009 PR Newswire.
All rights reserved